m+Medelevator.RU
← Поиск публикаций
Annals of medicine · 2025

Feasibility and safety of ipsilateral antegrade 4-French access in the endovascular treatment of peripheral artery disease.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kacała Arkadiusz, Fischer Jędrzej, Dorochowicz Mateusz, Chernyk Julia, Szydziak Joanna, Hrapkowicz Aleksandra, Wrześniewska Martyna, Wołoszczak Julia, Janowska Kinga, Litwinowicz Kamil, Szuba Andrzej, Guziński Maciej

Аннотация

INTRODUCTION: Traditionally, contralateral retrograde or ipsilateral antegrade 6 F access has been the predominant approach for endovascular interventions in peripheral artery disease (PAD). This study explores the feasibility and safety of using ipsilateral antegrade 4 F access as an alternative in the endovascular treatment of PAD.

OBJECTIVES: The objective of this study is to evaluate the technical success and complication rates associated with ipsilateral antegrade 4 F access in PAD patients undergoing endovascular procedures.

PATIENTS AND METHODS: This retrospective study included 113 PAD patients (77 males and 36 females) who underwent endovascular treatment using the ipsilateral antegrade 4 F technique between February 2020 and July 2023. Data on patient demographics, procedural characteristics, technical success, and periprocedural complications were collected and analyzed.

RESULTS: Complete technical success was achieved in 106 cases (93.8%), partial technical success in 6 cases (5.3%), and technical failure in 1 case (0.9%). Complications occurred in 4 patients (3.5%), while 109 patients (96.5%) had no complications.

CONCLUSIONS: Ipsilateral antegrade 4 F access demonstrates high technical success and low complication rates, suggesting it is a viable and safe alternative for endovascular treatment of PAD. However, further prospective studies are recommended to validate these findings and to assess the long-term safety and effectiveness of this technique.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты